0000899243-17-005329.txt : 20170224
0000899243-17-005329.hdr.sgml : 20170224
20170224210030
ACCESSION NUMBER: 0000899243-17-005329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170222
FILED AS OF DATE: 20170224
DATE AS OF CHANGE: 20170224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kusserow Paul B. K.
CENTRAL INDEX KEY: 0001456688
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 17639405
MAIL ADDRESS:
STREET 1: 780 SAN YSIDRO ROAD
CITY: SANTA BARBARA
STATE: CA
ZIP: 93108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-22
0
0000896262
AMEDISYS INC
AMED
0001456688
Kusserow Paul B. K.
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
1
1
0
0
CEO and President
Common Stock
2017-02-22
4
M
0
18750
0.00
A
94376
D
Common Stock
2017-02-22
4
F
0
7859
48.47
D
86517
D
Common Stock
128
I
Through 401(k) Plan
Performance-Based Restricted Shares
2017-02-22
4
M
0
18750
0.00
D
Common Stock
18750
37500
D
Stock Option (Right to Buy)
26.78
2017-02-22
4
A
0
62500
0.00
A
2017-02-22
2025-03-31
Common Stock
62500
62500
D
Each performance-based restricted share represents a contingent right to receive one share of of unrestricted common stock. The performance-based restricted shares shall vest, if at all, based on the certification by the Comensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal years 2015 through 2018, respectively (subject to certain pro-rated vesting provisions as provided in the award agreement for the performance-based restricted shares). The performance criteria for fiscal year 2016 were met. The number of performance-based restricted shares listed in Table II, Column 9 represents the maximum number of shares of unrestricted common stock the Reporting Person would receive based on the satisfaction of all of the remaining pre-determined performance goals.
On March 31, 2015, the reporting person was granted an option to purchase 250,000 shares of common stock. The option vests based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance of criteria for 2016 were met, resulting in vesting of the option as to 62,500 shares.
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2017-02-24